MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Scales"

  • 2016 International Congress

    Comorbid conditions associated with Parkinson´s disease: A longitudinal study

    D. Santos García, E. Suarez Castro, I. Expósito, T. de Deus, C. Tuñas, D. Núñez Arias, Á. Aneiros, M. López Fernández, J. Naveiro, J. Abella, M.A. Llaneza, V. Vilas, M. Macías (Ferrol, Spain)

    Objective: (1)To study what comorbid conditions were present at baseline and 3 years later in a cohort of Spanish PD patients and (2) to analyze…
  • 2016 International Congress

    Scores and dimensions to assess cognitive impairment in Parkinson’s disease

    I. Liepelt-Scarfone, S. Gräber, A. Pilotto, D. Blum, M. Fruhmann Berger, D. Berg (Tübingen, Germany)

    Objective: To provide inside into the nature of cognitive deterioration in Parkinson's disease dementia (PDD) and to define a score discriminating PDD patients from non-demented…
  • 2016 International Congress

    Measuring interdependence of the health status of people with Parkinson’s disease and their spouses

    F. Noubary, S.D. Gunnery, E.M. Naumova, M. Saint-Hilaire, C.A. Thomas, L. Tickle-Degnen (Boston, MA, USA)

    Objective: To demonstrate an innovative visualization method for measuring the interdependence of the health status of people with Parkinson's disease (PD) and their spouses over…
  • 2016 International Congress

    Staging of cognitive impairment: Validation of a novel cognitive score with [18F]FDG-PET

    D. Blum, M. Reimold, W. Maetzler, C. la Fougère, G. Reischl, D. Berg, I. Liepelt-Scarfone (Tübingen, Germany)

    Objective: To provide insight into the nature of cognitive deterioration and Parkinson's disease dementia (PDD) and to validate a novel cognitive score (also submitted for…
  • 2016 International Congress

    Clinically ‘slight’ bradykinesia in Parkinson’s disease is accurately detected using evolutionary computation analysis of finger tapping

    J.E. Alty, J. Cosgrove, M.A. Lones, S.L. Smith, K. Possin, N. Schuff, S. Jamieson (Leeds, United Kingdom)

    Objective: To assess whether MDS-UPDRS grade one Parkinson's disease (PD) bradykinesia can be accurately detected by a novel non-invasive device that analyses a standard finger…
  • 2016 International Congress

    Cognition and amyloid biomarker status in non-demented patients with Parkinson’s disease patients (PD) with or without subjective cognitive decline (SCD)

    I. Liepelt-Scarfone, F. Klumpp, W. Maetzler, S. Nussbaum, M. Timmers, G. Salvadore, M. Albers, K. Michaelis, Z. Tkaczynska, J. Streffer, D. Berg (Tübingen, Germany)

    Objective: To compare the cognitive and Amyloid-beta 1-42 profile of non-demented Parkinson's disease patients (PD) reporting subjective cognitive decline (SCD) with or without concerns regarding…
  • 2016 International Congress

    Testing feasibility and utility of remote data capture technology to assess Parkinson’s disease

    J. Carter, N. Hellmers, A. Hanineva, C. Henchcliffe (New York, NY, USA)

    Objective: To test feasibility and utility of home-based video-recording uploaded from a mobile device app to a cloud-based storage platform, in order to quantitate motor…
  • 2016 International Congress

    Disease-related variables effect on depression and anxiety level in Parkinson’s patients

    T. Uyar, D. Sarikaya Varlik, A. Ercan, O.C. Cenker, I. Gungor Dogan (Rize, Turkey)

    Objective: To evaluate correlations of depression and anxiety levels with motor symptoms, non-motor symptoms and pharmacological factors in Parkinson's disease (PD). Background: Depression and anxiety…
  • 2016 International Congress

    Cortical impairment as marker of dementia risk in probable REM sleep behavior disorder in Parkinson’s disease

    A.D. Santana-Vargas, H. Duran-Meza, J.D. Ramirez-Diossa, G.H. Terrazas Gonzalez, M. Lopez-Ruiz, G. Millan-Rosas, U. Jimenez-Correa (Mexico City, Mexico)

    Objective: To assess utility of Parkinson's disease-cognitive rating scale (PD-CRS) to detect Mild cognitive impairment (MCI) and dementia risk in a Parkinson's disease (PD) subpopulation.…
  • 2016 International Congress

    Evaluating bradykinesia: How many finger taps are needed?

    E. Ruzicka, R. Krupicka, K. Zarubova, J. Rusz, R. Jech, D. Stanek, Z. Szabo (Praha, Czech Republic)

    Objective: To assess the utility of finger tapping (FT) test to evaluate bradykinesia in Parkinson's disease (PD) at short and long FT sequences. Background: Repetitive…
  • « Previous Page
  • 1
  • …
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #28953 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley